Infektionsmedizin und Zoonosen
print

Links und Funktionen

Navigationspfad


Inhaltsbereich

Zitationsanalyse der ISI Web of Knowledge 2016

  • Gesamtzahl der bewerteten Publikationen von Prof. Dr. Gerd Sutter:
    139 (1991-2016)
  • Summe der Zitierungen: 7.164
  • Mittlere Anzahl der Zitierungen pro Publikation: 41,89
  • h-index: 44
    Der h-index (Hirsch-Index, auch Hirschfaktor, Hirsch-Koeffizient oder h-number) ist ein bibliometrisches Maß, das auf Zitationen der Publikationen eines Autors zu einem Zeitpunkt basiert.
Most Cited Papers
RankPaperNo. of Citations
1. A Toll-like receptor-independent antiviral response induced by double-stranded B-form DNA.
Ishii K., Coban C., Kato H., Tatahashi K., Torii Y., Takeshita F., Ludwig H., Sutter G., Suzuki K., Hemmi H., Sato S., Yamamoto M., Uematsu S., Kawai T., Takeuchi O., Akira S.
Nature Immunol 7:40-48 (2006)
509
2. Nonreplicating vaccinia vector efficiently expresses recombinant genes.
Sutter G., Moss B.
PNAS USA 89:10847-10851 (1992)
447
3. Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence.
Meyer H., Sutter G., Mayr A.
J Gen Virol 72:1031-1038 (1991)
308
4. Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus Ankara.
Hirsch V., Fuerst T., Sutter G., Carroll M., Yang L., Goldstein S., Piatak M., Elkins W., Montefiori D., Moss B., Lifson J.
J Virol 70:3741-3752 (1996)
281
5. IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice.
Bronte V., Serafini P., De Santo C., Marigo I., Tosello V., Mazzoni A., Segal D., Staib C., Lowel M., Sutter G., Colombo M., Zanovello P.
J Immunol 170:270-278 (2003)
242
6. A recombinant vector derived from the host range-restricted and highly attenuated MVA strain of vaccinia virus stimulates protective immunity in mice to influenza virus.
Sutter G., Wyatt L., Foley P., Bennink J., Moss B.
Vaccine 12:1032-1040 (1994)
213
7. Immunization of rhesus macaques with a DNA prime/modified vaccinia virus Ankara boost regimen induces broad simian immunodeficiency virus (SIV)-specific T-cell responses and reduces initial viral replication but does not prevent disease progression following challenge with pathogenic SIVmac239.
Horton H., Vogel T.U., Carter D.K., Vielhuber K., Fuller D.H., Shipley T., Fuller J.T., Kunstman K.J., Sutter G., Montefiori D.C., Erfle V., Desrosiers R.C., Wilson N., Picker L.J., Wolinsky S.M., Wang C., Allison D.B., Watkins D.I.
J Virol 76:7187-7202 (2002)
174
8. Highly attenuated modified vaccinia virus Ankara (MVA) replicates in baby hamster kidney cells (BHK), a potential host for virus propagation, but not in various human transformed and primary cells.
Drexler I., Heller K., Wahren B., Erfle V., Sutter G.
J Gen Virol 79:347-352 (1998)
168
9. Non-replicating vaccinia vector efficiently expresses bacteriophage T7 RNA polymerase.
Sutter G., Ohlmann M., Erfle V.
FEBS Letters 371:9-12 (1995)
162
10. Immune escape of melanoma: First evidence of structural alterations in two distinct components of the MHC class I antigen processing pathway.
Seliger B., Ritz U., Abele R., Bock M., Tampe R., Sutter G., Drexler I., Huber C., Ferrone S.
Cancer Research 61:8647-8650 (2001)
107

Verantwortlich für den Inhalt: Wanda Schroppa